Michael Belhumeur
Optometrist · Latham, NYNPI 1467971200
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 157 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by Tarsus Pharmaceuticals, Inc. at 31.6% of the total. 2025 is the largest year on record at $2,710, more than ten times the $164 reported in 2023. Among optometrist clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 157 payments — averaging $26.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Tarsus Pharmaceuticals, Inc.$1K
- Bausch & Lomb Americas Inc.$1K
- AbbVie$760
- Oyster Point Pharma, Inc.$199
- Amgen$121
- Sun Pharmaceutical Industries Inc.$119
- plus $416 from 11 others
What the payments were for
- Food & beverage$4,126100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Tarsus Pharmaceuticals, Inc. | 60 | $1,303 |
| Bausch & Lomb Americas Inc. | 36 | $1,208 |
| AbbVie | 20 | $760 |
| Oyster Point Pharma, Inc. | 10 | $199 |
| Amgen(2 entities) | 5 | $121 |
| Sun Pharmaceutical Industries Inc. | 5 | $119 |
| Dompe US, Inc. | 4 | $75 |
| Astellas Pharma US Inc | 3 | $64 |
| Alcon | 3 | $60 |
| Rayner Intraocular Lenses Limited | 3 | $56 |
| Biotissue Holdings Inc. | 2 | $38 |
| Halozyme Inc | 1 | $28 |
| Mallinckrodt Hospital Products Inc. | 1 | $25 |
| AstraZeneca | 1 | $24 |
| Thea Pharma Inc. | 1 | $16 |
| Argenx US, Inc. | 1 | $14 |
| Apellis Pharmaceuticals, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,126 in reported general payments places this provider in the 90th percentile of 2,743 optometrist providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Timolol Maleate | 20 | $1,600 |
| Tobramycin-DexamethasoneTobramycin/Dexamethasone | 37 | $1,542 |
| Prednisolone Acetate | 35 | $1,173 |
| ErythromycinErythromycin Base | 49 | $1,020 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 74 | $986 |
| Latanoprost | 53 | $784 |
| Doxycycline Monohydrate | 11 | $107 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Latham
- Roy KlineLake Katrine$822K
- Susan ResnickNew York$463K
- Murray FingeretHewlett$374K
- Albert MorierSlingerlands$347K
- Denise WhittamNew York$343K
- Justin BazanBrooklyn$303K
- Jennifer TsaiNew York$275K
- Alexander KabiriQueens Village$268K
- Sophia VisanjiNew York$233K
- Jason ComptonNew York$181K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.